Stocklytics Platform
Asset logo for symbol OABIW
OmniAb
OABIW3
$0.30arrow_drop_up5.26%$0.01
Penny Stock
Asset logo for symbol OABIW
OABIW3

$0.30

arrow_drop_up5.26%

Performance History

Chart placeholder
Key Stats
Open$0.28
Prev. Close$0.28
EPS-
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$0.00
PE Ratio-
LOWHIGH
Day Range0.28
0.30
52 Week Range0.23
1.25
Ratios
Revenue-
EPS-

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About OmniAb (OABIW)

OmniAb, Inc. (OABIW) is a leading biotechnology company that specializes in the development and commercialization of human therapeutic antibodies. The company utilizes its proprietary OmniRat, OmniMouse, and OmniFlic platforms to generate fully human antibodies with high affinity and specificity. These platforms have revolutionized the field of antibody discovery and have enabled the development of novel and highly effective therapeutic antibodies.
One of the key factors that investors often consider when evaluating a company is its stock price history. Unfortunately, the stock price history for OmniAb, Inc. (OABIW) is not readily available. It is important to note that a company's stock price can be influenced by a variety of factors, including market conditions, industry trends, and company-specific news. Therefore, it is important for investors to carefully analyze these factors before making any investment decisions.
Sector
Industry
CEO
Headquarters
Employees
0
Exchange
NASDAQ
add OmniAb to watchlist

Keep an eye on OmniAb

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is OmniAb (OABIW) stock price performance year to date (YTD)?

As of the latest data, OmniAb (OABIW) has a year-to-date price change of -72.22%. Over the past month, the stock has experienced a price change of -7.69%. Over the last three months, the change has been -17.63%.
help

What is OmniAb's (OABIW) price per share?

The current price per share for OmniAb (OABIW) is $0.3. The stock has seen a price change of $0.02 recently, indicating a 5.26% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for OmniAb (OABIW)?

For OmniAb (OABIW), the 52-week high is $1.25, which is 316.67% from the current price. The 52-week low is $0.24, the current price is 26.05% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is OmniAb (OABIW) a growth stock?

OmniAb (OABIW) has shown an average price growth of -6.03% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying OmniAb as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

Is OmniAb (OABIW) a profitable company?

OmniAb (OABIW) has a net income of -$50.62M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 42.93% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -473.73% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $14.67M. Operating income is noted at -$69.42M. Furthermore, the EBITDA is -$62.02M.
help

What is the market capitalization of OmniAb (OABIW)?

OmniAb (OABIW) has a market capitalization of $0. The average daily trading volume is 0.29, indicating the stock's liquidity and investor engagement.

News

Take Your Investments to a Whole New Level